Krishna Institute of Medical Sciences Limited (BOM:543308)
India · Delayed Price · Currency is INR | Market Cap | 303.65B +19.5% |
| Revenue (ttm) | 39.05B +28.6% |
| Net Income | 2.41B -37.2% |
| EPS | 6.03 -37.2% |
| Shares Out | n/a |
| PE Ratio | 125.79 |
| Forward PE | 70.93 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 17,302 |
| Open | 758.75 |
| Previous Close | 758.35 |
| Day's Range | 746.40 - 774.30 |
| 52-Week Range | 575.55 - 798.00 |
| Beta | n/a |
| Analysts | Strong Buy |
| Price Target | 826.00 (+9.61%) |
| Earnings Date | May 15, 2026 |
About BOM:543308
Krishna Institute of Medical Sciences Limited provides medical and health care services under the KIMS Hospitals brand in India. The company offers neurology, neurosurgery, psychiatry, and neuro rehabilitation; cardiology, cardiac and vascular surgery, heart transplant, and cardio rehabilitation; and pulmonology, interventional pulmonology, thoracic surgery, and lung transplant. It also provides medical and surgical gastroenterology, hepatobiliary pancreatic surgery, liver transplant, and bariatric surgery; ear, nose, throat, and head and neck ... [Read more]
Financial Performance
In fiscal year 2026, BOM:543308's revenue was 39.05 billion, an increase of 28.65% compared to the previous year's 30.35 billion. Earnings were 2.41 billion, a decrease of -37.22%.
Financial StatementsNews
Krishna Institute of Medical Sciences Transcript: Q4 25/26
Revenue grew 35% YoY in Q4 FY26, but EBITDA margin declined due to new unit ramp-up and expansion. Mature units maintained strong margins, while new units narrowed losses; QIP will reduce debt and fund further growth. Insurance empanelment delays remain a key risk.
Krishna Institute of Medical Sciences Quarterly report: Q4 2026
Krishna Institute of Medical Sciences has published its Q4 2026 quarterly earnings report on May 18, 2026.
Krishna Institute of Medical Sciences Slides: Q4 2026
Krishna Institute of Medical Sciences has posted slides in relation to its Q4 2026 quarterly earnings report, which was published on May 18, 2026.
Krishna Institute of Medical Sciences Transcript: Q3 25/26
Q3 FY26 saw record revenue above INR 1,000 crore, with strong growth in new hospitals but margin pressure from ramp-up costs. Debt has peaked and is expected to moderate as CapEx winds down, while break-even is targeted soon for new units.
Krishna Institute of Medical Sciences Quarterly report: Q3 2026
Krishna Institute of Medical Sciences has published its Q3 2026 quarterly earnings report on February 8, 2026.
Krishna Institute of Medical Sciences Slides: Q3 2026
Krishna Institute of Medical Sciences has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on February 8, 2026.
Krishna Institute of Medical Sciences Transcript: Q2 25/26
Q2 FY26 saw 23% revenue growth but EBITDA and EPS declined due to new hospital ramp-up costs. Margin expansion is expected as new units break even, with Andhra and Telangana clusters maintaining strong profitability. CGHS price hikes and insurance empanelment will support future margins.
Krishna Institute of Medical Sciences Quarterly report: Q2 2026
Krishna Institute of Medical Sciences has published its Q2 2026 quarterly earnings report on November 9, 2025.
Krishna Institute of Medical Sciences Slides: Q2 2026
Krishna Institute of Medical Sciences has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on November 9, 2025.
Krishna Institute of Medical Sciences Transcript: Q1 25/26
Revenue grew 26.8% YoY to INR 879 crore, with EBITDA at INR 200 crore and margin at 22.7%. New units in Thane, Bangalore, and Kerala are ramping up, with initial losses expected to neutralize within 12 months. Net debt stands at INR 2,020 crore, and ARPOB is projected to rise as new facilities mature.
Krishna Institute of Medical Sciences Quarterly report: Q1 2026
Krishna Institute of Medical Sciences has published its Q1 2026 quarterly earnings report on August 7, 2025.
Krishna Institute of Medical Sciences Slides: Q1 2026
Krishna Institute of Medical Sciences has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on August 7, 2025.